Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated less than a minute ago
EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines
about 2 hours ago
EMA’s 2025 annual report shows strong approval numbers for human and veterinary...
Human medicines European public assessment report (EPAR): Edistride, dapagliflozin, Date of authorisation: 09/11/2015, Revision: 27, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Edistride, dapagliflozin, Date of authorisation...
Shortage prevention plan (SPP) workshop, Online, from 22 June 2026, 10:30 (CEST) to 22 June 2026, 12:30 (CEST)
about 3 hours ago
Shortage prevention plan (SPP) workshop, Online, from 22 June 2026, 10:30 (CEST)...
Change management activities delivery plan - HMA-EMA joint Big Data Steering Group
about 4 hours ago
Change management activities delivery plan - HMA-EMA joint Big Data Steering Group
Managing product data quality in PMS: processes, known issues, current status and best practices, Online, from 21 July 2026, 14:00 (CEST) to 21 July 2026, 15:30 (CEST)
about 21 hours ago
Managing product data quality in PMS: processes, known issues, current status and...
Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), paliperidone, Date of authorisation: 18/06/2020, Revision: 5, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International)...
Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation...
Human medicines European public assessment report (EPAR): Vargatef, nintedanib, Date of authorisation: 21/11/2014, Revision: 22, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Vargatef, nintedanib, Date of authorisation...
Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation: 19/02/2018, Revision: 18, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 17, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 29, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation...